Use of 852A in Metastatic Cutaneous Melanoma.

Clinical trial NCT00189332 · COMPLETED

Trial details

NCT number: NCT00189332
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Unresectable Metatstatic Cutaneous Melanoma

Start date: 2005-02-01
Primary completion: 2006-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.